Study on the Recovery of Visual Perceptual Function Dysfunction in Patients With Diabetes
1 other identifier
interventional
36
1 country
1
Brief Summary
Investigators aim to investigate the effectiveness of visual perceptual learning on visual perceptual function in participants with diabetic retinopathy and to provide novel therapeutic insights for visual functional rehabilitation in diabetic retinopathy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 9, 2024
CompletedFirst Submitted
Initial submission to the registry
July 16, 2025
CompletedFirst Posted
Study publicly available on registry
July 31, 2025
CompletedJuly 31, 2025
July 1, 2025
1.4 years
July 16, 2025
July 23, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
contrast sensitivity
The contrast sensitivity measurements include grating acuity, first-order motion stimulus perception sensitivity, second-order stationary stimulus perception sensitivity and second-order motion stimulus perception sensitivity, which represent the reciprocal of the contrast threshold.
From enrollment to the end of treatment at 12 weeks
Secondary Outcomes (1)
The Low Vision Quality of Life Questionnaire
From enrollment to the end of treatment at 12 weeks
Other Outcomes (1)
The Hospital Anxiety and Depression Scale
From enrollment to the end of treatment at 12 weeks
Study Arms (2)
visual perceptual learning group
EXPERIMENTALcontrol group
NO INTERVENTIONInterventions
Participants in the VPL group performed 40 minutes of daily monocular training at home for three months, with follow-up evaluations conducted at 1 month and 3 months after training initiation.
Eligibility Criteria
You may qualify if:
- moderate to severe non-proliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy(PDR) prior to treatment(17)
- prior pan retinal laser photocoagulation (PRP) at least 4 weeks before enrollment or vitreoretinal surgery at least 8 weeks before enrollment
- stable clinical condition
- best-corrected visual acuity (BCVA) \> 1.0 logMAR (equivalent to a Snellen visual acuity of \< 20/200)
- clear refractive media
- age ≤ 65 years
- ability to comprehend the examination and training procedures
You may not qualify if:
- significant refractive media opacity
- psychiatric disorders, chronic alcoholism and traumatic brain injury
- new-onset vitreous hemorrhage, myopia, strabismus, amblyopia, glaucoma and macular diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief physician, Doctoral supervisor
Study Record Dates
First Submitted
July 16, 2025
First Posted
July 31, 2025
Study Start
March 1, 2023
Primary Completion
July 31, 2024
Study Completion
August 9, 2024
Last Updated
July 31, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to ethical and privacy considerations. Participants did not consent to data sharing in the informed consent form.